INFECTIOUS / GI CONDITION · CONDITION GUIDE
Abdominal Tuberculosis
Tuberculous infection affecting the intestines, peritoneum, and lymph nodes — requiring anti-tuberculous therapy as primary treatment, with surgery for complications such as obstruction, perforation, or abscess.
ABOUT THIS CONDITION
What is Abdominal Tuberculosis?
Abdominal tuberculosis (TB) is caused by Mycobacterium tuberculosis involving the gastrointestinal tract, peritoneum, mesentery, and lymph nodes. It is particularly prevalent in South Asia. It may present as intestinal obstruction from strictures, acute abdomen from perforation, ascites from peritoneal involvement, or as a chronic wasting illness with abdominal pain and altered bowel habit. Diagnosis is confirmed by tissue biopsy, AFB culture, or GeneXpert PCR. Dr. Tagore Mohan Grandhi manages surgical complications of abdominal tuberculosis at Lux Hospitals, Hyderabad. Anti-tuberculous therapy (ATT) is the cornerstone of treatment. Surgery is reserved for complications not amenable to medical therapy — bowel obstruction, perforation, abscess, or fistula. Short bowel-conserving resections with temporary stoma formation are performed to manage complications safely.
SIGNS TO WATCH
Common Symptoms
Symptoms that need attention
WHY IT HAPPENS
Causes & Risk Factors
- Mycobacterium tuberculosis infection via ingested organisms or haematogenous spread from pulmonary TB
- Ileocaecal region most commonly affected due to high lymphoid tissue density
- Immunosuppression from HIV, diabetes, malnutrition, or corticosteroid use
- Endemic exposure in regions of high TB prevalence
- Inadequately treated or drug-resistant pulmonary tuberculosis
- Consumption of unpasteurised milk with M. bovis in rural settings
CLINICAL DETAILS
KeyFacts
Anti-tuberculous therapy (ATT) for 6‒9 months
Ileocaecal region
Obstruction, perforation, fistula, abscess
Temporary stoma commonly used to manage contamination
Biopsy with AFB stain, culture, or GeneXpert PCR
Available at Lux Hospitals, Hitech City, Hyderabad
HOW WE TREAT IT
Treatment Approach
Anti-Tuberculous Therapy First
Anti-tuberculous therapy is the definitive treatment for abdominal tuberculosis. Surgery is performed only for complications that do not respond to medical therapy. Dr. Grandhi works closely with infectious disease physicians to ensure appropriate ATT is started promptly, minimising the need for surgical intervention and optimising surgical outcomes when surgery is required.
- 1
Diagnosis & Infectious Disease Review
CT abdomen, colonoscopy with biopsy, ascitic fluid analysis, and GeneXpert PCR confirm the diagnosis. HIV testing and sputum culture exclude pulmonary TB. Infectious disease team initiates ATT.
- 2
Anti-Tuberculous Therapy
Standard first-line ATT (rifampicin, isoniazid, pyrazinamide, ethambutol) is commenced for 2 months, followed by a continuation phase. Most patients improve significantly without surgery.
- 3
Surgery for Complications
Bowel obstruction from ileocaecal stricture not resolving on ATT requires laparoscopic or open resection. Perforation requires emergency resection and peritoneal washout with temporary stoma formation.
- 4
Post-operative ATT & Nutritional Support
ATT is continued for the full treatment duration of 6‒9 months post-operatively. Nutritional rehabilitation, iron supplementation, and close follow-up monitor for disease recurrence.
AVAILABLE TREATMENTS
TreatmentOptions
Primary Bowel Resection
Resection of the diseased ileocaecal or intestinal segment with primary anastomosis for obstruction or stricture not responding to medical therapy.
Bowel Resection with Colostomy
Resection with stoma formation for perforated bowel or severely contaminated abdomen where primary anastomosis is unsafe.
Ileostomy
Formation of a defunctioning ileostomy to protect a distal anastomosis or manage complex fistulas in the context of active tuberculosis.
COMMON QUESTIONS
Frequently Asked Questions
Not sure about your condition?
Compassionate, confidential consultations — Book your appointment today.